Lansing Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Sell
10,355
-123
-1% -$7.06K 0.13% 99
2026
Q1
$635K Buy
10,478
+285
+3% +$16.6K 0.16% 90
2025
Q4
$550K Sell
10,193
-68
-0.7% -$3.27K 0.14% 95
2025
Q3
$463K Buy
10,261
+34
+0.3% +$1.59K 0.12% 99
2025
Q2
$473K Sell
10,227
-3,403
-25% -$167K 0.14% 93
2025
Q1
$831K Sell
13,630
-757
-5% -$44.1K 0.28% 60
2024
Q4
$814K Sell
14,387
-2,590
-15% -$145K 0.28% 50
2024
Q3
$878K Sell
16,977
-505
-3% -$23.7K 0.32% 47
2024
Q2
$726K Buy
17,482
+184
+1% +$8.23K 0.3% 55
2024
Q1
$938K Buy
17,298
+8,595
+99% +$438K 0.42% 46
2023
Q4
$447K Buy
+8,703
New +$457K 0.23% 59
2023
Q2
$1.56M Buy
24,387
+1,398
+6% +$93.7K 0.9% 26
2023
Q1
$1.59M Sell
22,989
-7,660
-25% -$540K 1% 25
2022
Q4
$2.21M Buy
30,649
+1,568
+5% +$118K 1.51% 18
2022
Q3
$2.07M Buy
29,081
+1,210
+4% +$87.8K 1.6% 18
2022
Q2
$2.15M Buy
27,871
+134
+0.5% +$10.2K 1.67% 16
2022
Q1
$2.16M Buy
+27,737
New +$1.86M 1.37% 22

Other funds holding BMY

Lansing Street Advisors's BMY Position: Q2 2026 in Review

Lansing Street Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, selling an estimated $7.06K and leaving 10,355 shares worth $597K. The position accounts for 0.13% of the portfolio, ranked #99.

Lansing Street Advisors first reported a position in BMY in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.21M in Q4 2022. 949 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Lansing Street Advisors held 10,355 shares of Bristol-Myers Squibb worth $597K as of Q2 2026.
  • Lansing Street Advisors sold 123 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.06K.
  • Bristol-Myers Squibb made up 0.13% of Lansing Street Advisors's portfolio in Q2 2026, its #99 holding.
  • Lansing Street Advisors first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 17 quarters since.
  • Lansing Street Advisors's Bristol-Myers Squibb position peaked at $2.21M in Q4 2022.
  • 949 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Lansing Street Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.